[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.173.45. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 761
Citations 0
Correction
January 2018

Open Access Information Added

JAMA Oncol. 2018;4(1):133. doi:10.1001/jamaoncol.2017.4703

In the Original Article titled “Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay,”1 published online October 26, 2017, information about the Open Access status was added to the acknowledgments. This article has been corrected online.

References
1.
Tsai  M, Lo  S, Audeh  W,  et al.  Association of 70-gene signature assay findings with physicians’ treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay  [published online October 26, 2017].  JAMA Oncol. doi:10.1001/jamaoncol.2017.3470Google Scholar
×